Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort.
Overview & Synopsis
Open access biomedical research article published in Breast.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort. |
|---|---|
| Author / Organization | Grinda T, Carton M, Morganti S, Mailliez A, Levy C, Petit T, Bachelot T, Arnedos M, Diéras V, Massard V, Dalenc F, Desmoulins I, Pierga JY, Gonçalves A, Bailleux C, Frenel JS, Bosquet L, Parsons HA, Jacot W, Lin NU |
| Subject & Discipline | Breast |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-40600 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |